Literature DB >> 20607994

Antimicrobial suceptibility of V. cholerae in north west, Ethiopia.

Bayeh Abera1, Belaye Bezabih, Azene Dessie.   

Abstract

OBJECTIVES: Various Vibrio cholerae serogroups cause cholera, which occurs as major epidemic disease in most developing countries. This study was aimed at determining the antimicrobial susceptibility patterns of V. cholerae and its serotypes from cholera cases.
METHODS: The study was undertaken during cholera epidemics in North West Ethiopia from August 2006 to September 2008. Diarrheic stool samples were processed per the standard microbiology procedures at Bahir Dar Regional Health Research Laboratory. Antimicrobial susceptibility tests were performed using disc diffusion technique per Kirby-Bauer method.
RESULTS: Eighty one V. cholerae 01 serotype Inaba were isolated from stools of cholera cases. Antibiograms of V. cholerae 01 Inaba showed that 71.6% of isolates were resistant against two, 18.4% to three and 5% to four antibiotics. All V. cholerae Inaba isolates were resistant to co-trimoxazol 81 (100%). High levels of resistance were also shown to chloramphenicol 76 (94%) and ampicillin 72 (89%) with least resistance to erythromycin 12 (15%), tetracycline 5 (6.2) and ciprofloxacilin 1 (1.2%). However, all isolates remain susceptible to doxycycline 81 (100%).
CONCLUSION: In the study area, doxycycline or ciprofloxacilin could be used for treatment of adult cholera cases whereas erythromycin is alternative for young children. Antimicrobial susceptibility tests are strongly recommended for V. cholerae strains in treatment intervention during epidemics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607994

Source DB:  PubMed          Journal:  Ethiop Med J        ISSN: 0014-1755


  5 in total

Review 1.  Diagnosis, Management, and Future Control of Cholera.

Authors:  Fahima Chowdhury; Allen G Ross; Md Taufiqul Islam; Nigel A J McMillan; Firdausi Qadri
Journal:  Clin Microbiol Rev       Date:  2022-06-21       Impact factor: 50.129

2.  A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better?

Authors:  Sylvia Omulo; Samuel M Thumbi; M Kariuki Njenga; Douglas R Call
Journal:  Antimicrob Resist Infect Control       Date:  2015-01-28       Impact factor: 4.887

3.  Epidemiologic and Drug Resistance Pattern of Vibrio cholerae O1 Biotype El Tor, Serotype Ogawa, in the 2011 Cholera Outbreak, in Alborz Province, Iran.

Authors:  Hojatolah Barati; Ghobad Moradi; Mohammad Aziz Rasouli; Parvin Mohammadi
Journal:  Jundishapur J Microbiol       Date:  2015-11-14       Impact factor: 0.747

Review 4.  Vibrio Pathogens: A Public Health Concern in Rural Water Resources in Sub-Saharan Africa.

Authors:  Charles A Osunla; Anthony I Okoh
Journal:  Int J Environ Res Public Health       Date:  2017-10-07       Impact factor: 3.390

5.  Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: a systematic review and meta-analysis.

Authors:  Mohammad Hossein Ahmadi
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-06       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.